Rigel Pharmaceuticals Inc (RIGL)
R&D to Revenue
17.74%
Quarterly · Period ending:
RIGL R&D to Revenue
Latest reported17.74%period ending
Latest reported17.74%period ending
RIGL Quarterly R&D/Revenue (0.00% → 17.74%)
Latest values, visible window
High-resolution chart · PNG
RIGL r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 281.3641% | |
| 187.1321% | |
| 997.9439% | |
| 0% | |
| 0% | |
| 0% |